Inactive Instrument

Zinzino AB (publ) Stock Nasdaq Stockholm

Equities

SE0002480442

Other Specialty Retailers

Sales 2023 1.77B 162M Sales 2024 * 1.92B 176M Capitalization 2.43B 223M
Net income 2023 164M 15.07M Net income 2024 * 179M 16.45M EV / Sales 2023 1.29 x
Net Debt 2023 257M 23.63M Net Debt 2024 * 221M 20.31M EV / Sales 2024 * 1.38 x
P/E ratio 2023
12.6 x
P/E ratio 2024 *
14.1 x
Employees -
Yield 2023
5.03%
Yield 2024 *
2.81%
Free-Float 53.08%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 54 11-12-31
Director of Finance/CFO 47 08-12-31
Chief Tech/Sci/R&D Officer 48 17-12-31
Members of the board TitleAgeSince
Director/Board Member 60 06-12-31
Director/Board Member 56 -
Director/Board Member 52 -
More insiders
Zinzino AB is a Sweden-based global Company engaged in selling dietary supplements, skin care and lifestyle products. The Company specializes in biomarker-based, personalized nutrition and health tech. The Company’s test-based, scientifically proven nutritional supplements are available on more than 100 markets across the world. Zinzino AB owns the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The Company’s headquarter is in Gothenburg, Sweden with additional offices in Finland, Latvia, Norway, USA, Australia, Hong Kong, Malaysia and India.
Calendar
More about the company